RxDoctor Payments DataLook up a doctor →

Michael Rosemore, DO

Physical Medicine & Rehabilitation · Bessemer, ALNPI 1104849843

Payments from drug & device makers

$10,461in general payments, 2019–2025

Across 644 payments — averaging $16.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • GSK$1K
  • AbbVie$1K
  • Pfizer$791
  • Boehringer Ingelheim$690
  • AstraZeneca$639
  • plus $4K from 40 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk97$1,610
GSK90$1,376
AbbVie(2 entities)77$1,064
Pfizer51$791
Boehringer Ingelheim48$690
AstraZeneca37$639
Novartis35$577
Amgen25$471
Johnson & Johnson28$446
Lilly USA, LLC22$376
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC20$323
Merck17$266
Esperion Therapeutics, Inc.7$145
Mylan Specialty L.p.7$117
Xeris Pharmaceuticals, Inc.2$117
Amarin Pharma, Inc.7$112
Axsome Therapeutics, Inc.5$112
Astellas Pharma US Inc6$106
Bayer6$106
Boston Scientific3$92
Sanofi-aventis U.S. LLC4$80
Exact Sciences5$79
Sumitomo Pharma America, Inc.5$78
Eisai Inc.4$66
Shield Therapeutics Inc3$59
Ironshore Pharmaceuticals Inc.2$48
Abbott2$44
Lundbeck LLC2$41
Viatris Specialty LLC2$40
Ironwood Pharmaceuticals, Inc3$39
Biogen2$39
E.r. Squibb & Sons, L.L.C.3$37
Dynavax Technologies Corporation1$28
Paratek Pharmaceuticals, Inc.2$28
Otsuka America Pharmaceutical, Inc.2$27
Kowa Pharmaceuticals America, Inc.2$26
Ardelyx, Inc.1$22
Dexcom, Inc.1$21
Takeda Pharmaceuticals U.S.A., Inc.1$19
Scilex Pharmaceuticals Inc.1$18
Hikma Pharmaceuticals USA1$18
SK Life Science, Inc.1$16
Acadia Pharmaceuticals Inc1$15
Radius Health, Inc.1$13
Collegium Pharmaceutical, Inc.1$13
Biohaven Pharmaceutical Holding Company Ltd.1$13

How this compares

$10,461 in reported general payments places this provider in the 90th percentile of 104 physical medicine & rehabilitation providers in Alabama.

See all physical medicine & rehabilitation providers in Alabama →

Medicare billing

Part B allowed, 2024
$885,930
Medicare patients
1,258
Services billed
10,227

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physical medicine & rehabilitation in Bessemer

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →